Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Strasser

Showing results (271-280 of 320) with videos related to

Pageof 32
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2011
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737Samantha R Oakes, François Vaillant, Elgene Lim, et al.
Nature|February 28, 2014
Is SIRT2 required for necroptosis?Kim Newton, Joanne M Hildebrand, Zhirong Shen, et al.
Cell Death and Differentiation|February 24, 2023
Correction to: The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cellsZilu Wang, Huimin Hu, Luuk Heitink, et al.
Cell Death and Differentiation|February 4, 2023
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cellsZilu Wang, Huimin Hu, Luuk Heitink, et al.
Molecular Oncology|January 9, 2022
In vivo genome-editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesisLuuk Heitink, James R Whittle, François Vaillant, et al.
Cell Death and Differentiation|December 14, 2023
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responsesJohn E La Marca, Brandon J Aubrey, Bruce Yang, et al.
Cell Death and Differentiation|January 29, 2020
Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cellsCharis E Teh, Jia-Nan Gong, David Segal, et al.
EMBO Reports|July 4, 2014
Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome primingRamanjaneyulu Allam, Kate E Lawlor, Eric Chi-Wang Yu, et al.
Nature Medicine|February 4, 2014
Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomasShoukat Afshar-Sterle, Dimitra Zotos, Nicholas J Bernard, et al.
The EMBO Journal|August 19, 2024
Mouse models to investigate in situ cell fate decisions induced by p53Elizabeth Lieschke, Annabella F Thomas, Andrew Kueh, et al.
Pageof 32

Showing results (271-280 of 320) with videos related to

Sort By:
Pageof 32
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2011
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737Samantha R Oakes, François Vaillant, Elgene Lim, et al.
Nature|February 28, 2014
Is SIRT2 required for necroptosis?Kim Newton, Joanne M Hildebrand, Zhirong Shen, et al.
Cell Death and Differentiation|February 24, 2023
Correction to: The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cellsZilu Wang, Huimin Hu, Luuk Heitink, et al.
Cell Death and Differentiation|February 4, 2023
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cellsZilu Wang, Huimin Hu, Luuk Heitink, et al.
Molecular Oncology|January 9, 2022
In vivo genome-editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesisLuuk Heitink, James R Whittle, François Vaillant, et al.
Cell Death and Differentiation|December 14, 2023
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responsesJohn E La Marca, Brandon J Aubrey, Bruce Yang, et al.
Cell Death and Differentiation|January 29, 2020
Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cellsCharis E Teh, Jia-Nan Gong, David Segal, et al.
EMBO Reports|July 4, 2014
Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome primingRamanjaneyulu Allam, Kate E Lawlor, Eric Chi-Wang Yu, et al.
Nature Medicine|February 4, 2014
Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomasShoukat Afshar-Sterle, Dimitra Zotos, Nicholas J Bernard, et al.
The EMBO Journal|August 19, 2024
Mouse models to investigate in situ cell fate decisions induced by p53Elizabeth Lieschke, Annabella F Thomas, Andrew Kueh, et al.
Pageof 32